ClinicalTrials.gov record
Completed Not applicable Interventional

Effect of Interleukin-2 on HIV Treatment Interruption

ClinicalTrials.gov ID: NCT00015704

Public ClinicalTrials.gov record NCT00015704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Pilot Study Utilizing CD4 T-Cell Counts Lower Than 350 Cells/mm3 as the Threshold for Restarting Therapy With Potent Antiretroviral Therapy With or Without Interleukin-2 to Determine the Effect of Pulse Therapy on the Characteristics of Treatment Interruptions

Study identification

NCT ID
NCT00015704
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
80 participants

Conditions and interventions

Conditions

Interventions

  • Aldesleukin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Oct 31, 2004
Last update posted
Oct 31, 2021

Ends 2004

United States locations

U.S. sites
17
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
UCLA CARE Center CRS Los Angeles California
Stanford CRS Palo Alto California 943055107
Santa Clara Valley Med. Ctr. San Jose California
San Mateo County AIDS Program San Mateo California 943055107
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
University of Minnesota, ACTU Minneapolis Minnesota 55455
Washington U CRS St Louis Missouri 63108
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr. Omaha Nebraska 681985130
Beth Israel Med. Ctr., ACTU New York New York 10003
Cornell CRS New York New York 10021
Weill Med. College of Cornell Univ., The Cornell CTU New York New York
Unc Aids Crs Chapel Hill North Carolina
Duke Univ. Med. Ctr. Adult CRS Durham North Carolina 27710
Case CRS Cleveland Ohio 44106
MetroHealth CRS Cleveland Ohio 441091998
Pitt CRS Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00015704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00015704 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →